Skip to content
HUHUHU150/12.5150/12.5150/12.5

Drawing based on the label description. No photo yet.

“Irbesartan and hydrochlorothiazide tablets USP, 150 mg/12.5 mg are peach color, oval biconvex, film-coated tablets, debossed with "HU" on one side and "150/12.5" on the other side”

HU 150125 pill

Pill with imprint HU 150125 is pink, oval, 12 mm and has been identified as Irbesartan and Hydrochlorothiazide 150 mg / 12.5 mg. It is used for high blood pressure. It is supplied by Hisun Pharmaceuticals USA Inc.

Irbesartan and Hydrochlorothiazide 150 mg / 12.5 mg

Imprint
HU 150125
Strength
Irbesartan 150 mg / Hydrochlorothiazide 12.5 mg
Used for
High blood pressure
Color
Pink
Shape
Oval
Size
12 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Hisun Pharmaceuticals USA Inc
Drug class
ARB (blood pressure medicine)
NDC
42658-141, 42658-141-01, 42658-141-04, 42658-141-07

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Irbesartan and Hydrochlorothiazide pills and guides

What is Irbesartan and Hydrochlorothiazide used for?

Irbesartan and Hydrochlorothiazide is used for high blood pressure.

Medicine type
ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label

Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension.

Irbesartan and hydrochlorothiazide tablets may be used in patients whose blood pressure is not adequately controlled on monotherapy.

Irbesartan and hydrochlorothiazide tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.

The choice of irbesartan and hydrochlorothiazide tablets as initial therapy for hypertension should be based on an assessment of potential benefits and risks.

Patients with stage 2 (moderate or severe) hypertension are at relatively high risk for cardiovascular events (such as strokes, heart attacks, and heart failure), kidney failure, and vision problems, so prompt treatment is clinically relevant. The decision to use a combination as initial therapy should be individualized and may be shaped by considerations such as the baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared with monotherapy.

Data from Studies V and VI provide estimates of the probability of reaching a blood pressure goal with irbesartan and hydrochlorothiazide tablets compared to irbesartan or hydrochlorothiazide (HCTZ) monotherapy. The relationship between baseline blood pressure and achievement of a SeSBP <140 or <130 mmHg or SeDBP <90 or <80 mmHg in patients treated with irbesartan and hydrochlorothiazide tablets compared to patients treated with irbesartan or HCTZ monotherapy are shown in Figures 1a through 2b.

*For all probability curves, patients without blood pressure measurements at Week 7 (Study VI) and Week 8 (Study V) were counted as not reaching goal (intent-to-treat analysis).

The above graphs provide a rough approximation of the likelihood of reaching a targeted blood pressure goal (e.g., Week 8 sitting systolic blood pressure ≤140 mmHg) for the treatment groups. The curve of each treatment group in each study was estimated by logistic regression modeling from all available data of that treatment group. The estimated likelihood at the right tail of each curve is less reliable due to small numbers of subjects with high baseline blood pressures.

For example, a patient with a blood pressure of 180/105 mmHg has about a 25% likelihood of achieving a goal of <140 mmHg (systolic) and 50% likelihood of achieving <90 mmHg (diastolic) on irbesartan alone (and lower still likelihoods on HCTZ alone).

The likelihood of achieving these goals on irbesartan and hydrochlorothiazide tablets rises to about 40% (systolic) or 70% (diastolic).

From the FDA-approved label on DailyMed (published Jul 08, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows HU and the other side shows 150/12.5.
  • It is pink, oval, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Irbesartan, Hydrochlorothiazide

Inactive: Cellulose, Microcrystalline, Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Hypromellose 2910 (5 Mpa.s), Magnesium Stearate, Hypromellose 2910 (15 Mpa.s), Titanium Dioxide, Polyethylene Glycol 3350, Ferric Oxide Yellow, Ferric Oxide Red

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Irbesartan and Hydrochlorothiazide pills